F-group (family)
1.1.1.7 tRNA-synt_1_2
Ligands and drugs
1,493
Member domains
71
with ligand contacts (≤ 4 Å)
4.8% of members
53
with DrugDomain annotations
3.5% of members
29
with a DrugBank compound
1.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1.1.1.7 belongs to X-group 1 cradle loop barrel, which binds 9.4 ligand superclasses per 20 proteins, broader than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 4 |
| DB01755 | ILA | N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone | 4 |
| DB04185 | NVA | Norvaline | 4 |
| DB00167 | ILE | Isoleucine | 3 |
| DB04102 | 2AD | 2-Amino-Adenosine | 3 |
| DB00134 | MET | Methionine | 2 |
| DB00149 | — | Leucine | 1 |
| DB00161 | — | Valine | 1 |
| DB02916 | LMS | [(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate | 1 |
| DB03355 | TSB | 5'-O-(L-Threonylsulfamoyl)adenosine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 5 |
| ILA | N-[ISOLEUCINYL]-N'-[ADENOSYL]-DIAMINOSUFONE | 4 |
| NVA | NORVALINE | 4 |
| VRT | 2'-(L-NORVALYL)AMINO-2'-DEOXYADENOSINE | 4 |
| 2AD | 2'-AMINO-2'-DEOXYADENOSINE | 3 |
| 7RZ | [(1R,3'S,5S,6R,8R)-3'-(aminomethyl)-8-(6-aminopurin-9-yl)-4'-bromanyl-7'-[3-[methyl-(phenylmethyl)amino]propoxy]spiro[2,4,7-trioxa-3$l^{4}-borabicyclo[3.3.0]octane-3,1'-3H-2,1$l^{4}-benzoxaborole]-6-yl]methyl dihydrogen phosphate | 3 |
| ZNmetal | ZINC ION | 3 |
| 365 | [(1S,5R,6R,7'S,8R)-7'-(aminomethyl)-6-(6-aminopurin-9-yl)-2'-(3-oxidanylpropoxy)spiro[2,4,7-trioxa-3-boranuidabicyclo[3.3.0]octane-3,9'-8-oxa-9-boranuidabicyclo[4.3.0]nona-1(6),2,4-triene]-8-yl]methyl dihydrogen phosphate | 2 |
| 9YN | (2~{S})-~{N}-[(2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl]-2-azanyl-4-methyl-pentanamide | 2 |
| CL | CHLORIDE ION | 2 |
| ILE | ISOLEUCINE | 2 |
| MET | METHIONINE | 2 |
| TAR | D(-)-TARTARIC ACID | 2 |
| 38Y | 3-(AMINOMETHYL)-4-BROMO-7-ETHOXYBENZO[C][1,2]OXABOROL-1(3H)-OL-MODIFIED ADENOSINE | 1 |
| 81D | (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol | 1 |
| A2H | 4-Chloro-3-aminomethyl-7-[ethoxy]-3H-benzo[C][1,2]oxaborol-1-ol modified adenosine | 1 |
| A52 | 3-AMINOMETHYL-7-(ETHOXY)-3H-BENZO[C][1,2]OXABOROL-1-OL modified adenosine | 1 |
| ANZ | [(6-AMINO-9H-PURIN-9-YL)-[5-FLUORO-1,3-DIHYDRO-1-HYDROXY-2,1-BENZOXABOROLE]-4'YL]METHYL DIHYDROGEN PHOSPHATE | 1 |
| CAmetal | CALCIUM ION | 1 |
| EYT | [(1~{R},5~{S},6~{R},8~{R},9'~{S})-9'-(aminomethyl)-8-(6-aminopurin-9-yl)-2'-bromanyl-5'-[3-oxidanylidene-3-(1,3-thiazol-2-ylamino)propoxy]spiro[2,4,7-trioxa-3-boranuidabicyclo[3.3.0]octane-3,7'-8-oxa-7-boranuidabicyclo[4.3.0]nona-1(6),2,4-triene]-6-yl]methyl dihydrogen phosphate | 1 |